19769 studies found for:    T
Show Display Options
Rank Status Study
1 Terminated A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
Condition: Alzheimers Disease
Intervention: Radiation: [F18] T808
2 Completed
Has Results
Can Oral T3 Normalize Thyroid Hormone Levels Following Cardiopulmonary Bypass in Children?
Condition: Low T3 Syndrome
Interventions: Drug: Oral T3 Low dose;   Drug: Placebo;   Drug: Oral T3 high dose
3 Not yet recruiting Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation
Condition: Patients Undergoing Allogeneic Stem Cell Transplantation
Intervention: Biological: CMV/EBV specific T-cell
4 Recruiting Central Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma
Conditions: Adult Acute Lymphoblastic Leukemia in Remission;   B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Chronic Lymphocytic Leukemia;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Biological: autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells;   Other: laboratory biomarker analysis
5 Completed
Has Results
Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-Hep B-PRP~T combined vaccine + Pneumococcal polysaccharide;   Biological: DTaP-Hep B-IPV // Hib Vaccine + Pneumococcal polysaccharide;   Biological: DTaP-IPV-Hep B-PRP~T + Pneumococcal polysaccharide vaccine
6 Completed CEA-Expressing Liver Metastases Safety Study of Intrahepatic Infusions of Anti-CEA Designer T Cells
Condition: Liver Metastases
Intervention: Biological: anti-CEA 2nd generation designer T cells
7 Completed Assessment of the Clinical Efficacy and Acceptability of Think Positive (T+) in Diabetes Management
Condition: Diabetes (Insulin-requiring, Type 1 or Type 2)
Intervention: Device: Mobile phone telehealth application: Think Positive (T+)
8 Terminated Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Condition: Colorectal Cancer
Intervention: Biological: Gene Modified T Cells
9 Active, not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
Conditions: Adult Grade III Lymphomatoid Granulomatosis;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Post-transplant Lymphoproliferative Disorder;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Hairy Cell Leukemia;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Biological: autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells;   Procedure: autologous hematopoietic stem cell transplantation;   Other: laboratory biomarker analysis
10 Recruiting Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment
Condition: Actinic Keratosis
Interventions: Drug: SR-T100  gel;   Drug: Vehicle gel
11 Recruiting Home-based Program "T&E" for Fall Prevention and QoL in Elderly: a Randomised Control Pilot-study
Condition: Accidental Falls
Interventions: Other: T&E;   Other: OTAGO
12 Recruiting Autologous CD19-specific T Cells Infusion
Conditions: Lymphoma;   B-cell Lymphoma
Interventions: Procedure: Leukapheresis;   Procedure: Stem Cell Transplant;   Procedure: CD19-specific T Cell Infusion;   Drug: IL-2;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan
13 Not yet recruiting T-ABA Group Based Early Intervention For Parents of Children With ASD
Condition: Autism
Intervention: Behavioral: Targeted Applied Behavioral Analysis (T-ABA)
14 Recruiting Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System
Conditions: Partial Edentulism;   Tooth Disease
Interventions: Device: T3 with DCD tapered Prevail implant;   Device: Nanotite Certain tapered implant
15 Active, not recruiting Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Biological: Gene Modified T Cells;   Biological: Gene Modified T Cells and Interleukin 2
16 Terminated Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies
Conditions: Leukemia;   Lymphoma;   Myeloma
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Mesna;   Radiation: Radiation Treatment;   Procedure: Stem Cell Transplantation (SCT);   Drug: Sirolimus;   Procedure: Anti-third Party Cytolytic T-lymphocytes (CTL)
17 Not yet recruiting Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
Condition: Head and Neck Cancer
Intervention: Other: Intra-tumoral T4 immunotherapy
18 Not yet recruiting Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Adult Acute Megakaryoblastic Leukemia (M7);   Adult Acute Minimally Differentiated Myeloid Leukemia (M0);   Adult Acute Monoblastic Leukemia (M5a);   Adult Acute Monocytic Leukemia (M5b);   Adult Acute Myeloblastic Leukemia With Maturation (M2);   Adult Acute Myeloblastic Leukemia Without Maturation (M1);   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Acute Myelomonocytic Leukemia (M4);   Adult Erythroleukemia (M6a);   Adult Pure Erythroid Leukemia (M6b);   Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: cyclophosphamide;   Biological: anti CD123-CAR/CD28-costimulatory, retroviral vector-transduced autologous T lymphocytes;   Other: laboratory biomarker analysis
19 Recruiting CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study
Conditions: Peripheral T-cell Lymphoma NOS;   Anaplastic Large Cell Lymphoma, ALK-Negative;   Angioimmunoblastic T-cell Lymphoma;   Hepatosplenic Gamma/ Delta T-cell Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Gemcitabine;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisolone;   Drug: methylprednisolone;   Drug: Cisplatin
20 Completed
Has Results
A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Hepatitis B;   Poliomyelitis
Interventions: Biological: DTaP-IPV-Hep B-PRP-T  Vaccine;   Biological: DTaP-Hep B-IPV vaccine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years